Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 515, doi. 10.1007/s11899-019-00556-2
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2019 AND VI 14 AND IP 6
Results: 12
1
2
What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 477, doi. 10.1007/s11899-019-00555-3
- By:
- Publication type:
- Article
3
Mutation-Driven Therapy in MDS.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 550, doi. 10.1007/s11899-019-00554-4
- By:
- Publication type:
- Article
4
Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 543, doi. 10.1007/s11899-019-00553-5
- By:
- Publication type:
- Article
5
Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 523, doi. 10.1007/s11899-019-00552-6
- By:
- Publication type:
- Article
6
Early Management of CML.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 480, doi. 10.1007/s11899-019-00550-8
- By:
- Publication type:
- Article
7
The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 501, doi. 10.1007/s11899-019-00549-1
- By:
- Publication type:
- Article
8
Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients with Chronic Myeloid Leukaemia in Clinical Practice.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 507, doi. 10.1007/s11899-019-00548-2
- By:
- Publication type:
- Article
9
The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS).
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 536, doi. 10.1007/s11899-019-00547-3
- By:
- Publication type:
- Article
10
Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 492, doi. 10.1007/s11899-019-00546-4
- By:
- Publication type:
- Article
11
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 570, doi. 10.1007/s11899-019-00545-5
- By:
- Publication type:
- Article
12
Driving the CAR to the Bone Marrow Transplant Program.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 6, p. 561, doi. 10.1007/s11899-019-00544-6
- By:
- Publication type:
- Article